Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1109448 NASHVILLE, TN
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$44,566
+$23,605 QoQ
Shares Held
34,020
-27.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 130 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. LCTX ranks #251 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in LCTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,566 34,020
2025-03-31 $20,961 46,580
2024-12-31 $23,290 46,580
2024-09-30 $42,387 46,580
2024-06-30 $46,580 46,580
2024-03-31 $26,240 17,730
2023-12-31 $19,325 17,730
2023-09-30 $20,921 17,730
2023-06-30 $18,245 12,940
2022-03-31 $42,350 27,500
2021-12-31 $82,810 33,800
2021-09-30 $85,176 33,800
2021-06-30 $96,330 33,800
2020-03-31 $83,166 100,200